Search results :

Pomalidomide

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2
Neutropenia 2% - 52.3% x x
Asthenia 11.2% - 62.5% x
Diarrhoea 33% - 33.6% x x
Anaemia 20.5% - 45.7% x x
Nausea 22.3% - 35.5% x x
Upper respiratory tract infection 25% - 31.8% x x
Thrombocytopenia 1.7% - 27% x x
Musculoskeletal chest pain 19.6% - 21.5% x
Fatigue 4.7% - 62.5% x x
Decreased appetite 17.9% - 21.5% x x
Rash 16.1% - 21.5% x x
Constipation 0.935% - 35.5% x x
Muscle spasms 18.7% - 18.8% x x
Dizziness 17% - 19.6% x x
Cough 14% - 20.5% x x
Pneumonia 9% - 28.6% x x
Arthralgia 15.2% - 15.9% x
Oedema peripheral 1.3% - 23.4% x x
Vomiting 13.4% - 14% x x
Hyperglycaemia 12.1% - 15.2% x
Musculoskeletal pain 11.2% - 15.2% x
Epistaxis 10.7% - 15% x
Pruritus 10.7% - 15% x x
Confusional state 10.3% - 13.4% x x
Body temperature increased 2.8% - 30.4% x x
Hyponatraemia 10.3% - 12.5% x x
Weight decreased 8.04% - 14% x
Tremor 9.35% - 12.5% x x
Hyperhidrosis 5.61% - 16.1% x
Headache 8.04% - 13.1% x
Back pain 1.79% - 31.8% x
Leukopenia 5.61% - 17.9% x x
Hypokalaemia 10.3% - 10.7% x
Insomnia 6.54% - 14.3% x
Chills 9.35% - 10.7% x
Dry skin 9.35% - 10.7% x
Dyspnoea 4.67% - 44.6% x x
Pain in extremity 4.67% - 14.3% x
Anxiety 7.14% - 11.2% x
Renal failure 6.25% - 15% x x
Neuropathy peripheral 7.14% - 10.3% x
Hypocalcaemia 5.61% - 11.6% x
Muscular weakness 3.57% - 12.1% x
Night sweats 4.67% - 12.5% x
Bone pain 4.46% - 12.1% x x
Blood creatinine increased 2.68% - 15% x
Hypercalcaemia 0.893% - 20.6% x
Urinary tract infection 0% - 16.1% x
Weight increased 0.935% - 10.7% x
Lymphopenia 1.87% - 15.2% x
Pain 4.46% - 5.61% x
Sepsis 2.68% - 5.61% x
Febrile neutropenia 0.893% - 4.67% x x
Dehydration 2.68% - 4.67% x
Atrial fibrillation 1.87% - 2.68% x
Cardiac failure congestive 0% - 2.68% x
General physical health deterioration 0% - 1.79% x
Pancytopenia postmarketing x
Tumour lysis syndrome postmarketing x
Congenital anomaly x
Mental disorder x x
Breast disorder x x
Bronchitis x
Bronchopneumonia x
Infection x x
Connective tissue disorder x x
Gastrointestinal disorder x x
Cardiac disorder x
Hyperbilirubinaemia x x
Hyperkalaemia x x
Hypersensitivity x
Mediastinal disorder x x
Nasopharyngitis x
Nervous system disorder x x
Pelvic pain x x
Pulmonary embolism x
Respiratory syncytial virus infection x
Respiratory tract infection x
Urinary tract disorder x x
Angiopathy x
Vertigo x x
Urinary retention x x
Deep vein thrombosis x
Peripheral sensory neuropathy x
Alanine aminotransferase increased x x
Malnutrition x x
Unspecified disorder of skin and subcutaneous tissue x x
Interstitial lung disease x
Teratogenicity x
Hepatobiliary disease x x
Platelet count decreased x
Neuropathy x x
Depressed level of consciousness x
White blood cell count decreased x
Infestation NOS x x
Blood and lymphatic system disorders x x
Ear and labyrinth disorders x x
Neutrophil count decreased x
Thromboembolic event x
Neutropenic sepsis x x
Pneumocystis jirovecii pneumonia x
Venous thromboembolism x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

pomalidomide / pomalidomide

Side effects:63
Source:EMA

POMALIDOMIDE

Side effects:87
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label